Financial Services -
Insurance - Specialty - NASDAQ - US
$ 36.59
-0.875 %
$ 5.54 B
Market Cap
8.16
P/E
1. INTRINSIC VALUE
Balance Sheet
Enact Holdings, Inc.
| Current Assets | 6.22 B |
| Cash & Short-Term Investments | 6.22 B |
| Receivables | 53 M |
| Other Current Assets | -53 M |
| Non-Current Assets | 65 M |
| Long-Term Investments | 3.37 M |
| PP&E | 0 |
| Other Non-Current Assets | 61.6 M |
| Current Liabilities | 537 M |
| Accounts Payable | 0 |
| Short-Term Debt | 0 |
| Other Current Liabilities | 537 M |
| Non-Current Liabilities | 743 M |
| Long-Term Debt | 743 M |
| Other Non-Current Liabilities | 0 |
EFFICIENCY
Earnings Waterfall
Enact Holdings, Inc.
| Revenue | 1.2 B |
| Cost Of Revenue | 0 |
| Gross Profit | 1.2 B |
| Operating Expenses | 213 M |
| Operating Income | 940 M |
| Other Expenses | 252 M |
| Net Income | 688 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Enact Holdings, Inc.
| Net Income | 688 M |
| Depreciation & Amortization | 0 |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 18.8 M |
| Change in Working Capital | -53 M |
| Others | -25 M |
| Free Cash Flow | 686 M |
Wall Street Analysts Price Targets
Enact Holdings, Inc.
Wall Street analysts predict an average 1-year price target for ACT of $30.2 , with forecasts ranging from
a
low of
$25 to a high of $33 .
ACT Lowest Price Target
Wall Street Target
25 USD
-31.68%
ACT Average Price Target
Wall Street Target
30.2 USD
-17.46%
ACT Highest Price Target
Wall Street Target
33 USD
-9.81%
4. DIVIDEND
ANALYSIS
0.53%
DIVIDEND YIELD
0 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Enact Holdings, Inc.
Sold
0-3 MONTHS
57.9 M USD 4
3-6 MONTHS
51.4 M USD 2
6-9 MONTHS
72.1 M USD 1
9-12 MONTHS
39.9 M USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Actinium Announces Enrollment of First Patient in the Iomab-ACT Commercial CAR-T Trial at the University of Texas Southwestern Medical Center
- Initial clinical data expected in the second half of 2025 from this first-of-its-kind trial to administer a targeted radiotherapy conditioning agent with a commercial CAR-T therapy - Iomab-ACT supported by results of NIH funded trial with MSK showing effective lymphodepletion of targeted immune cells resulting in negligible rates of CAR-T toxicities ICANS and CRS and CAR T-cell persistence with a novel CD19 CAR-T therapy - Iomab-ACT has the potential to increase the addressable market for CAR-T therapies, which generated $4 billion in sales in 2024, by enabling improved access and better patient outcomes compared to current chemotherapy conditioning agents NEW YORK , May 6, 2025 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced that the first patient was enrolled on the trial studying Iomab-ACT targeted conditioning with a commercial CAR-T therapy at the University of Texas Southwestern Medical Center (UTSW) (NCT06768905). Initial clinical data from this trial is expected in the second half of 2025.
prnewswire.com
- 2 weeks ago
4 Stocks to Watch That Recently Declared Dividend Hikes Amid Volatility
Stocks like ATKR, ACT, POOL and AWK recently announced dividend hikes.
zacks.com
- 2 weeks ago
Enact Holdings, Inc. (ACT) Q1 2025 Earnings Call Transcript
Enact Holdings, Inc. (NASDAQ:ACT ) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET Company Participants Daniel Kohl - Vice President of Investor Relations Rohit Gupta - President and Chief Executive Officer Dean Mitchell - Chief Financial Officer Conference Call Participants Mihir Bhatia - Bank of America Merrill Lynch Douglas Harter - UBS Richard Shane - JPMorgan Chase & Co. Bose George - Keefe, Bruyette, & Woods, Inc. Operator Hello, and welcome to Enact's First Quarter Earnings Call. Please be advised that today's conference is being recorded.
seekingalpha.com
- 2 weeks ago
Aduro Engages Siemens to Deliver Advanced Automation for Hydrochemolytic™ Pilot Plant
LONDON, Ontario, May 01, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, announced today a strategic collaboration with Siemens Canada , a leader in industrial automation and digitalization, to supply advanced control systems and engineering services for Aduro's Next Generation Process Pilot Plant (the “Pilot Plant”), scheduled for commissioning in Q3 2025. At the core of the solution is Siemens' SIMATIC PCS neo distributed control system—an advanced, web-based platform that will provide centralized, secure, and scalable process control for the continuous operation of the Pilot Plant.
globenewswire.com
- 2 weeks ago
Enact Holdings, Inc. (ACT) Lags Q1 Earnings and Revenue Estimates
Enact Holdings, Inc. (ACT) came out with quarterly earnings of $1.10 per share, missing the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $1.04 per share a year ago.
zacks.com
- 2 weeks ago
Enact Reports First Quarter 2025 Results
GAAP Net Income of $166 million , or $1.08 per diluted share Adjusted Operating Income of $169 million , or $1.10 per diluted share Return on Equity of 13.1% and Adjusted Operating Return on Equity of 13.4% Primary Insurance in-force of $268 billion , a 2% increase from first quarter 2024 PMIERs Sufficiency of 165% or approximately $2.0 billion Book Value Per Share of $33.96 and Book Value Per Share excluding AOCI of $34.97
globenewswire.com
- 2 weeks ago
Enact Announces 14% Increase to Quarterly Dividend and New $350 Million Share Repurchase Program
RALEIGH, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) announced that its Board of Directors declared a quarterly dividend of $0.21 per common share, an increase of 14% from the prior quarter's dividend. This dividend will be payable on June 11, 2025, to shareholders of record on May 19, 2025.
globenewswire.com
- 2 weeks ago
Blue Bird Showcases Zero- and Low-Emission Commercial Vehicle Platforms at 2025 Advanced Clean Transportation (ACT) Expo
MACON, Ga.--(BUSINESS WIRE)--Blue Bird Corporation (Nasdaq: BLBD), the leader in electric and low-emission school buses, showcases its latest zero- and ultra-low emission commercial vehicle platforms at the upcoming 2025 Advanced Clean Transportation (ACT) Expo, North America's largest advanced transportation technology event. The company presents both its groundbreaking electric step van and propane-powered stripped chassis at the industry event from April 28-30, 2025, at the Anaheim Conventio.
businesswire.com
- 2 weeks ago
Enact Holdings, Inc. (ACT) Reports Next Week: Wall Street Expects Earnings Growth
Enact Holdings (ACT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zacks.com
- 3 weeks ago
Electrovaya to Showcase New Battery Products at the Advanced Clean Transportation (ACT) Expo 2025
Electrovaya's Latest Battery Modules and Battery Systems that will be Manufactured in the USA will be on display at the ACT EXPO from April 28-30th at the Anaheim Convention Center TORONTO, ON / ACCESS Newswire / April 22, 2025 / Electrovaya Inc. (NASDAQ:ELVA)(TSX:ELVA), a leading lithium-ion battery technology and manufacturing company, announces that that it will be exhibiting at the Advanced Clean Transportation ("ACT") Expo2025, taking place on April 28 - April 30, 2025, at the Anaheim Convention Center in California, USA. Electrovaya will be exhibiting at Booth #3421 , where it will be showcasing its latest lithium ion battery cells, modules and battery systems which will be manufactured at scale at its gigafactory in Jamestown, New York.
accessnewswire.com
- 4 weeks ago
Phoenix Motors To Participate in the Advanced Clean Transportation (ACT) Expo at Anaheim Convention Center
ANAHEIM, CA / ACCESS Newswire / April 16, 2025 / Phoenix Motor Inc. dba PhoenixEV (NASDAQ:PEV), a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, is excited to announce its participation in the Advanced Clean Transportation (ACT) Expo, taking place from April 28 to May 1 at the Anaheim Convention Center. This prestigious event brings together industry leaders, innovators, and key stakeholders dedicated to advancing transportation solutions that prioritize sustainability and environmental responsibility.
accessnewswire.com
- 1 month ago
Enact to Host First Quarter 2025 Earnings Call May 1st
RALEIGH, N.C., April 10, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced it will issue its first quarter earnings release after the market closes on April 30, 2025. Enact will host a conference call to review first quarter 2025 financial results on May 1, 2025 at 8:00 a.m. (ET).
globenewswire.com
- 1 month ago
8. Profile
Summary
Enact Holdings, Inc. ACT
COUNTRY
US
INDUSTRY
Insurance - Specialty
MARKET CAP
$ 5.54 B
Dividend Yield
0.53%
Description
Enact Holdings, Inc. operates as a private mortgage insurance company in the United States. The company is involved in writing and assuming residential mortgage guaranty insurance. It offers private mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; and contract underwriting services for mortgage lenders. The company was formerly known as Genworth Mortgage Holdings, Inc. and changed its name to Enact Holdings, Inc. in May 2021. Enact Holdings, Inc. was founded in 1981 and is headquartered in Raleigh, North Carolina. Enact Holdings, Inc. is a subsidiary of Genworth Holdings, Inc.
Contact
8325 Six Forks Road, Raleigh, NC, 27615
https://www.enactmi.com
IPO
Date
Sept. 16, 2021
Employees
421
Officers
Mr. James Robert McMullen
Vice President, Controller & Principal Accounting Officer
Ms. Neenu Sohi Kainth
Senior Vice President & Chief Customer Experience Officer
Ms. Susan Gumm Sullivan
Senior Vice President & Chief Human Resources Officer
Mr. Hardin Dean Mitchell
Executive Vice President, Chief Financial Officer & Treasurer
Mr. Evan Scott Stolove
Executive Vice President, General Counsel & Secretary
Mr. Brian Michael Gould
EVice President & Chief Operating Officer
Mr. Michael Paul Derstine
Executive Vice President & Chief Risk Officer
Mr. Daniel Kohl
Vice President of Investor Relations
Mr. Rohit Gupta
President, Chief Executive Officer & Director
Mr. Matthew Robert Young
Senior Vice President of Sales